Similarities and differences in the characteristics and primary treatment of breast cancer in men and women – a population based study (Sweden)

References

• Stang A, Thomssen C. Decline in breast cancer incidence in the United States: what about male breast cancer? Breast Cancer Res Treat 2008;112:595–6.
   PubMedGoogle Scholar
• Anderson WF, Althuis MD, Brinton LA, Devesa SS. Is male breast cancer similar or different than female breast cancer? Breast Cancer Res Treat 2004;83:77–86.
   PubMed Web of Science ®Google Scholar
• NORDCAN [Internet]. Cancer incidence, mortality, prevalence and prediction in the Nordic countries. Available from: http://www.ancr.nu 2009.
   Google Scholar
• Nahleh ZA. Hormonal therapy for male breast cancer: A different approach for a different disease. Cancer Treat Rev 2006;32:101–5.
   PubMed Web of Science ®Google Scholar
• Anderson WF, Reiner AS, Matsuno RK, Pfeiffer RM. Shifting breast cancer trends in the United States. J Clin Oncol 2007;25:3923–9.
   PubMedGoogle Scholar
• Giordano SH. A review of the diagnosis and management of male breast cancer. Oncologist 2005;10:471–9.
   PubMed Web of Science ®Google Scholar
• Ottini L, Palli D, Rizzo S, Federico M, Bazan V, Russo A. Male breast cancer. Crit Rev Oncol Hematol 2010;73:141–55.
   PubMed Web of Science ®Google Scholar
• Nahleh ZA, Srikantiah R, Safa M, Jazieh AR, Muhleman A, Komrokji R. Male breast cancer in the veterans affairs population: A comparative analysis. Cancer 2007;109: 1471–7.
   PubMed Web of Science ®Google Scholar
• Cutuli B. Strategies in treating male breast cancer. Expert Opin Pharmacother 2007;8:193–202.
   PubMed Web of Science ®Google Scholar
• Giordano SH, Perkins GH, Broglio K, Garcia SG, Middleton LP, Buzdar AU, . Adjuvant systemic therapy for male breast carcinoma. Cancer 2005;104:2359–64.
   PubMed Web of Science ®Google Scholar
• Scott-Conner CE, Jochimsen PR, Menck HR, Winchester DJ. An analysis of male and female breast cancer treatment and survival among demographically identical pairs of patients. Surgery 1999;126:775–80; discussion 80–1.
   PubMed Web of Science ®Google Scholar
• Wang-Rodriguez J, Cross K, Gallagher S, Djahanban M, Armstrong JM, Wiedner N, . Male breast carcinoma: Correlation of ER, PR, Ki-67, Her2-Neu, and p53 with treatment and survival, a study of 65 cases. Mod Pathol 2002;15:853–61.
   PubMed Web of Science ®Google Scholar
• Wang J, Kollias J, Marsh C, Maddern G. Are males with early breast cancer treated differently from females with early breast cancer in Australia and New Zealand? Breast 2009;18:378–81.
   PubMed Web of Science ®Google Scholar
• Cutuli B, Le-Nir CC, Serin D, Kirova Y, Gaci Z, Lemanski C, . Male breast cancer. Evolution of treatment and prognostic factors. Analysis of 489 cases. Crit Rev Oncol Hematol 2010;73:246–54.
   PubMed Web of Science ®Google Scholar
• Czene K, Bergqvist J, Hall P, Bergh J. How to treat male breast cancer. Breast 2007;16(Suppl 2):S147–54.
   PubMedGoogle Scholar
• Marchal F, Salou M, Marchal C, Lesur A, Desandes E. Men with breast cancer have same disease-specific and event-free survival as women. Ann Surg Oncol 2009;16:972–8.
   PubMed Web of Science ®Google Scholar
• Willsher PC, Leach IH, Ellis IO, Bourke JB, Blamey RW, Robertson JF. A comparison outcome of male breast cancer with female breast cancer. Am J Surg 1997;173:185–8.
   PubMed Web of Science ®Google Scholar
• Dickman PW, Sloggett A, Hills M, Hakulinen T. Regression models for relative survival. Stat Med 2004;23:51–64.
   PubMed Web of Science ®Google Scholar
• Fentiman IS, Fourquet A, Hortobagyi GN. Male breast cancer. Lancet 2006;367:595–604.
   PubMed Web of Science ®Google Scholar
• Meijer-van Gelder ME, Look MP, Bolt-de Vries J, Peters HA, Klijn JG, Foekens JA. Clinical relevance of biologic factors in male breast cancer. Breast Cancer Res Treat 2001;68:249–60.
   PubMed Web of Science ®Google Scholar
• Giordano SH, Cohen DS, Buzdar AU, Perkins G, Hortobagyi GN. Breast carcinoma in men: A population-based study. Cancer 2004;101:51–7.
   PubMed Web of Science ®Google Scholar
• Barlund M, Kuukasjarvi T, Syrjakoski K, Auvinen A, Kallioniemi A. Frequent amplification and overexpression of CCND1 in male breast cancer. Int J Cancer 2004;111: 968–71.
   PubMed Web of Science ®Google Scholar
• Rayson D, Erlichman C, Suman VJ, Roche PC, Wold LE, Ingle JN, . Molecular markers in male breast carcinoma. Cancer 1998;83:1947–55.
   PubMed Web of Science ®Google Scholar
• Chakravarthy A, Kim CR. Post-mastectomy radiation in male breast cancer. Radiother Oncol 2002;65:99–103.
   PubMed Web of Science ®Google Scholar
• Gennari R, Curigliano G, Jereczek-Fossa BA, Zurrida S, Renne G, Intra M, . Male breast cancer: A special therapeutic problem. Anything new? (Review). Int J Oncol 2004;24:663–70.
   PubMed Web of Science ®Google Scholar
• Korde LA, Zujewski JA, Kamin L, Giordano S, Domchek S, Anderson WF, . Multidisciplinary meeting on male breast cancer: Summary and research recommendations. J Clin Oncol 2010;28:2114–22.
   PubMed Web of Science ®Google Scholar
• Johansson I, Nilsson C, Berglund P, Strand C, Jonsson G, Staaf J, . High-resolution genomic profiling of male breast cancer reveals differences hidden behind the similarities with female breast cancer. Breast Cancer Res Treat 2010 Nov 27. [Epub ahead of print]
   Web of Science ®Google Scholar
• Callari M, Cappelletti V, De Cecco L, Musella V, Miodini P, Veneroni S, . Gene expression analysis reveals a different transcriptomic landscape in female and male breast cancer. Breast Cancer Res Treat 2010;127:601–10.
   PubMed Web of Science ®Google Scholar
• Eaker S, Hellström V, Zack MW, Ahlgren J, Holmberg L, Uppsala Örebro Breast Cancer Group. Regional differences in Breast Cancer Survival Despite Common Guidelines. Cancer Epidemiol Biomarkers Prev 2005;14:2914–8.
   PubMed Web of Science ®Google Scholar